P00533 |
EGFR_HUMAN |
Non-small cell lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P00533 |
EGFR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P00533 |
EGFR_HUMAN |
Angina pectoris [ICD-11: BA40] |
P00533 |
EGFR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P00533 |
EGFR_HUMAN |
Colon cancer [ICD-11: 2B90] |
P00533 |
EGFR_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P00533 |
EGFR_HUMAN |
Diabetic foot ulcer [ICD-11: BD54] |
P00533 |
EGFR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P00533 |
EGFR_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
P00533 |
EGFR_HUMAN |
Ischemia [ICD-11: 8B10-8B11] |
P00533 |
EGFR_HUMAN |
Liver cancer [ICD-11: 2C12] |
P00533 |
EGFR_HUMAN |
Lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Melanoma [ICD-11: 2C30] |
P00533 |
EGFR_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P00533 |
EGFR_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P00533 |
EGFR_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
P00533 |
EGFR_HUMAN |
Skin postprocedural disorder [ICD-11: EL8Y] |
P00533 |
EGFR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P00533 |
EGFR_HUMAN |
Stomach cancer [ICD-11: 2B72] |
P00533 |
EGFR_HUMAN |
Unspecific body region injury [ICD-11: ND56] |
P00533 |
EGFR_HUMAN |
Urethral cancer [ICD-11: 2C93] |
P00533 |
EGFR_HUMAN |
Brain cancer [ICD-11: 2A00] |
P00533 |
EGFR_HUMAN |
Hypopharyngeal cancer [ICD-11: 2B6D] |
P00533 |
EGFR_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P00533 |
EGFR_HUMAN |
Metastatic biliary tract neoplasms [ICD-11: 2C14-2C17] |
P00533 |
EGFR_HUMAN |
Chronic pain [ICD-11: MG30] |
P00533 |
EGFR_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P00533 |
EGFR_HUMAN |
Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y] |
P00533 |
EGFR_HUMAN |
Non-small cell lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Intracerebral haemorrhage [ICD-11: 8B00] |
P00533 |
EGFR_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P00533 |
EGFR_HUMAN |
Metastatic lymph node neoplasm [ICD-11: 2D60] |
P00533 |
EGFR_HUMAN |
Spinal cord/cranial nerve neoplasm [ICD-11: 2A02] |
P00533 |
EGFR_HUMAN |
Testicular cancer [ICD-11: 2C80] |
P00533 |
EGFR_HUMAN |
Esophageal cancer [ICD-11: 2B70] |
P00533 |
EGFR_HUMAN |
Psoriasis [ICD-11: EA90] |
P00533 |
EGFR_HUMAN |
Digestive system disease [ICD-11: DE2Z] |
P00533 |
EGFR_HUMAN |
Cerebral ischaemia [ICD-11: 8B1Z] |
P00533 |
EGFR_HUMAN |
Cryptosporidiosis [ICD-11: 1A32] |
P00533 |
EGFR_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P00533 |
EGFR_HUMAN |
Gram-positive bacterial infection [ICD-11: 1B74-1F40] |
P00533 |
EGFR_HUMAN |
Brain cancer [ICD-11: 2A00] |
P00533 |
EGFR_HUMAN |
Liver cancer [ICD-11: 2C12] |
P00533 |
EGFR_HUMAN |
Lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P52732 |
KIF11_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P52732 |
KIF11_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P52732 |
KIF11_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P52732 |
KIF11_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P52732 |
KIF11_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
P52732 |
KIF11_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P52732 |
KIF11_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P52732 |
KIF11_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P52732 |
KIF11_HUMAN |
Liver cancer [ICD-11: 2C12] |
P52732 |
KIF11_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
Q9HC29 |
NOD2_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
Q9HC29 |
NOD2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q9HC29 |
NOD2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
P43405 |
KSYK_HUMAN |
Eczema [ICD-11: EA80-EA89] |
P43405 |
KSYK_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P43405 |
KSYK_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P43405 |
KSYK_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P43405 |
KSYK_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P43405 |
KSYK_HUMAN |
Acquired hypomelanotic disorder [ICD-11: ED63] |
P43405 |
KSYK_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P43405 |
KSYK_HUMAN |
Atopic eczema [ICD-11: EA80] |
P43405 |
KSYK_HUMAN |
B-cell lymphoma [ICD-11: 2A86] |
P43405 |
KSYK_HUMAN |
Cutaneous lupus erythematosus [ICD-11: EB50-EB5Z] |
P43405 |
KSYK_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P43405 |
KSYK_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P43405 |
KSYK_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P43405 |
KSYK_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P43405 |
KSYK_HUMAN |
Urticaria [ICD-11: EB00-EB05] |
P43405 |
KSYK_HUMAN |
Asthma [ICD-11: CA23] |
P43405 |
KSYK_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P43405 |
KSYK_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P43405 |
KSYK_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
Q02643 |
GHRHR_HUMAN |
Bone growth disorder [ICD-11: FB86] |
Q02643 |
GHRHR_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02643 |
GHRHR_HUMAN |
Lipoatrophy/lipodystrophy [ICD-11: EF01] |
Q02643 |
GHRHR_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |